Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Neuropathology of Cognitive Impairment in Chronic Schizophrenia and Alzheimer’s Disease
EF 2023-24
Résumé
Alzheimer's Disease (AD) is the most common cause of dementia, a uniquely devastating condition which affects 597,000 Canadians and costs our healthcare system over $10.4 billion annually. The disease is known for its destruction to memory and cognition, the latter of which is also altered in schizophrenia. Neither has a cure. Schizophrenia is less common and transforms the way people interpret reality, and because of these similarities, studying both diseases at once is mutually informative. The human brain reacts to disease by altering its microscopic appearance, and a few brain cells in particular (astrocytes, microglia, and neurons) are especially important in governing this neurological response. Our preliminary data indicates that these cell types behave differently in the brain to elicit the cognitive dysfunction observed in AD and schizophrenia, suggesting that these similar symptoms are due to entirely different processes. The human brain is exceptionally difficult to study, and schizophrenia lacks a viable animal model to effectively capture the essence of the disease. As a result, these distinct processes of cognitive impairment remain completely unexplored. My research will aim to understand, for the first time, the distribution of cells and proteins in the human brain that are disrupted in AD and schizophrenia. I will directly compare healthy brains to those with each disease to assess how each condition is fundamentally unique. Gaining a better understanding of the specific signatures of Alzheimer’s Disease and schizophrenia has the potential to help develop treatments which can target such changes, which would be life-changing for patients and their families. This work may also extend to further research into other neurological and psychiatric conditions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506028
Name
Futhey Naomi
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neuropathology of Cognitive Impairment in Chronic Schizophrenia and Alzheimer’s Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Alzheimer'S Disease; Astrocytes; Cognitive Dysfunction; Microglia; Neurodegeneration; Neuroinflammation; Neuropathology; Neurosciences; Schizophrenia
Abstract
Alzheimer's Disease (AD) is the most common cause of dementia, a uniquely devastating condition which affects 597,000 Canadians and costs our healthcare system over $10.4 billion annually. The disease is known for its destruction to memory and cognition, the latter of which is also altered in schizophrenia. Neither has a cure. Schizophrenia is less common and transforms the way people interpret reality, and because of these similarities, studying both diseases at once is mutually informative. The human brain reacts to disease by altering its microscopic appearance, and a few brain cells in particular (astrocytes, microglia, and neurons) are especially important in governing this neurological response. Our preliminary data indicates that these cell types behave differently in the brain to elicit the cognitive dysfunction observed in AD and schizophrenia, suggesting that these similar symptoms are due to entirely different processes. The human brain is exceptionally difficult to study, and schizophrenia lacks a viable animal model to effectively capture the essence of the disease. As a result, these distinct processes of cognitive impairment remain completely unexplored. My research will aim to understand, for the first time, the distribution of cells and proteins in the human brain that are disrupted in AD and schizophrenia. I will directly compare healthy brains to those with each disease to assess how each condition is fundamentally unique. Gaining a better understanding of the specific signatures of Alzheimer’s Disease and schizophrenia has the potential to help develop treatments which can target such changes, which would be life-changing for patients and their families. This work may also extend to further research into other neurological and psychiatric conditions.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Futhey, Naomi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~